Anemia
News
First biosimilar launched in US
© Sandoz Inc. 2015 The leukocyte growth factor Zarxio (filgrastim-sndz), the first biosimilar product to gain approval from the US Food and Drug...
News
Eltrombopag approved to treat SAA in EU
The European Commission has approved eltrombopag (Revolade) for the treatment of adults with severe aplastic anemia (SAA) who were either...
News
Hydroxyurea boosts O2 saturations in children with sickle cell disease
Key clinical point: Nocturnal and awake oxygen saturations are higher in patients treated with hydroxyurea. Major finding: The hydroxyurea SCD...
News
FDA expands use of eltrombopag
Photo courtesy of GSK The US Food and Drug Administration (FDA) has approved an expanded use for eltrombopag (Promacta) to include children 1...
News
New HMA shows early promise for MDS/AML
Image by Christoph Bock Investigators say a novel hypomethylating agent (HMA) is safe and clinically active in patients with myelodysplastic...
News
Mutations linked to Fanconi anemia, repair pathway
Photo courtesy of NIGMS Investigators say they have identified mutations that cause Fanconi anemia and, in the process, gained new insight into...
News
Drug on fast track to treat aHUS
Image by Kevin MacKenzie The US Food and Drug Administration (FDA) has granted fast track designation to OMS721 for the treatment of atypical...
News
Lenalidomide can treat pulmonary sarcoidosis in MDS
Treatment with lenalidomide can have a significant effect on pulmonary sarcoidosis in myelodysplastic syndrome (MDS), according to a case study....
News
FDA grants drug orphan designation for ITP
Photo by Linda Bartlett The US Food and Drug Administration (FDA) has granted orphan designation to veltuzumab for the treatment of immune...
News
Inhibitor could treat range of hematologic disorders
A small molecule that targets the sonic Hedgehog signaling pathway has advanced to phase 2 trials in a range of hematologic disorders. In a phase...
News
CHMP recommends eltrombopag for SAA
The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended approval for eltrombopag (Revolade) as a...